Xcellcure

xcellcure is a startup biotechnology company focused on transforming modern cardiac care. we are excited to launch our first product the amiaware, currently available as an investigational use only device to aid in the prevention of recurrent heart attack through patient-centered risk stratification utilizing 13 novel biomarkers. the motif of our clinical approach is to noninvasively diagnose and prognosticate patients experiencing acute coronary symptoms in order to assist in patient monitoring, aid therapeutic selection, prevent fatality, and reduce morbidity of cardiovascular disease. we will be releasing a collection of cardiac devices for the research, clinical and point of care realms to supplement and improve current care and patient quality of life. xcellcure’s novel multimarker cardiac panel has application for emergency room personnel to quickly assess the probability of an impending heart attack. our first product, the amiaware, allows users insight to key clinical evidence